References
- Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet 2004;363:1783–1793.
- Sherer TB, Betarbet R, Greenamyre JT. Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs 2001;2:657–662.
- Beal MF. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann N Y Acad Sci 2003;991:120–131.
- Greenamyre JT, Sherer TB, Betarbet R, Panov AV. Complex I and Parkinson's disease. IUBMB Life 2001;52:135–141.
- Winklhofer KF, Haass C. Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta 2010;1802:29–44.
- Jenner P, Olanow CW. The pathogenesis of cell death in Parkinson's disease. Neurology 2006;66:S24–S36.
- Schapira AH, Jenner P. Etiology and pathogenesis of Parkinson's disease. Mov Disord 2011;26:1049–1055.
- Zhu J, Chu CT. Mitochondrial dysfunction in Parkinson's disease. J Alzheimers Dis 2010;20:S325–S334.
- Perier C, Bove J, Vila M. Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond. Antioxid Redox Signal 2012;16:883–895.
- Yao Z, Wood NW. Cell death pathways in Parkinson's disease: role of mitochondria. Antioxid Redox Signal 2009;11:2135–2149.
- Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000;346:1–8.
- Park SY, Lee SM, Shin SW, Park J-W. Inactivation of mitochondrial NADP+-dependent isocitrate dehydrogenase by hypochlorous acid. Free Radic Res 2008;48:467–473.
- Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG, et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 2010;207:339–344.
- Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010;17:225–234.
- Lee JH, Park J-W. Attenuated mitochondrial NADP+-dependent isocitrate dehydrogenase activity induces apoptosis and hypertrophy of H9c2 cardiomyocytes. Biochimie 2014;99:110–118.
- Ku HJ, Ahn Y, Lee JH, Park KM, Park J-W. IDH2 deficiency promotes mitochondrial dysfunction and cardiac hypertrophy in mice. Free Radic Biol Med 2015;80:84–92.
- Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2007;2:141–151.
- Kim SH, Yoo YH, Lee JH, Park JW. Mitochondrial NADP(+)-dependent isocitrate dehydrogenase knockdown inhibits tumorigenicity of melanoma cells. Biochem Biophys Res Commun 2014;451:246–251.
- Choi SH, Lee DY, Chung ES, Hong YB, Kim SU, Jin BK. Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem 2005;95:1755–1765.
- Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 1992;202:384–389.
- Moon JL, Kim SY, Shin SW, Park J-W. Regulation of brefeldin A-induced ER stress and apoptosis by mitochondrial NADP+-dependent isocitrate dehydrogenase. Biochem Biophys Res Commun 2012;417:760–764.
- Macleod MR, Allsopp TE, McLuckie J, Kelly JS. Serum withdrawal causes apoptosis in SHSY 5Y cells. Brain Res 2001;889:308–315.